Brain implant patients test new drug to calm epilepsy signals
NCT ID NCT07125261
Summary
This study is testing whether an experimental drug called BHV-7000 can reduce abnormal brain activity in people with epilepsy who have a special implanted brain device (RNS System). Five participants will take the drug for four weeks, and researchers will compare their brain recordings during treatment to periods before and after. The goal is to see if the drug helps control the electrical patterns linked to seizures, even if the person doesn't feel a seizure happening.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yale Comprehensive Epilepsy Center
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.